Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review

por Zhao, Liang, Chen, Jianhao, Pang, Yizhen, Fu, Kaili, Shang, Qihang, Wu, Hua, Sun, Long, Lin, Qin, Chen, Haojun
Publicado 2022

Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy

por Pang, Yizhen, Zhao, Liang, Fang, Jianyang, Chen, Jianhao, Meng, Lingxin, Sun, Long, Wu, Hua, Guo, Zhide, Lin, Qin, Chen, Haojun
Publicado 2023

Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of (68)Ga-Labeled FAPI Dimer

por Zhao, Liang, Niu, Bo, Fang, Jianyang, Pang, Yizhen, Li, Siyang, Xie, Chengrong, Sun, Long, Zhang, Xianzhong, Guo, Zhide, Lin, Qin, Chen, Haojun
Publicado 2022

Clinical Evaluation of (68)Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin α(v)β(3) in Various Cancer Types

por Zhao, Liang, Wen, Xuejun, Xu, Weizhi, Pang, Yizhen, Sun, Long, Wu, Xiaoming, Xu, Pengfei, Zhang, Jingjing, Guo, Zhide, Lin, Qin, Chen, Xiaoyuan, Chen, Haojun
Publicado 2023

Fibroblast Activation Protein-Targeted Radioligand Therapy with (177)Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study

por Fu, Hao, Huang, Jingxiong, Zhao, Tianzhi, Wang, Hongjian, Chen, Yuhang, Xu, Weizhi, Pang, Yizhen, Guo, Wei, Sun, Long, Wu, Hua, Xu, Pengfei, Su, Bishan, Zhang, Jingjing, Chen, Xiaoyuan, Chen, Haojun
Publicado 2023